- Home
- ABP vs ICU Comparison
ABP vs ICU Comparison
Compare ABP & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- ICU
- Stock Information
- Founded
- ABP 2004
- ICU 2018
- Country
- ABP United States
- ICU United States
- Employees
- ABP N/A
- ICU N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- ICU Health Care
- Exchange
- ABP Nasdaq
- ICU Nasdaq
- Market Cap
- ABP 12.1M
- ICU 10.4M
- IPO Year
- ABP N/A
- ICU N/A
- Fundamental
- Price
- ABP $0.27
- ICU $1.24
- Analyst Decision
- ABP Strong Buy
- ICU
- Analyst Count
- ABP 1
- ICU 0
- Target Price
- ABP $4.00
- ICU N/A
- AVG Volume (30 Days)
- ABP 17.5M
- ICU 115.6K
- Earning Date
- ABP 05-22-2025
- ICU 05-14-2025
- Dividend Yield
- ABP N/A
- ICU N/A
- EPS Growth
- ABP N/A
- ICU N/A
- EPS
- ABP N/A
- ICU N/A
- Revenue
- ABP $183,000.00
- ICU $135,000.00
- Revenue This Year
- ABP N/A
- ICU $648.15
- Revenue Next Year
- ABP N/A
- ICU $100.00
- P/E Ratio
- ABP N/A
- ICU N/A
- Revenue Growth
- ABP 50.00
- ICU N/A
- 52 Week Low
- ABP $0.23
- ICU $1.11
- 52 Week High
- ABP $13.00
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- ICU 37.68
- Support Level
- ABP N/A
- ICU $1.22
- Resistance Level
- ABP N/A
- ICU $1.30
- Average True Range (ATR)
- ABP 0.00
- ICU 0.06
- MACD
- ABP 0.00
- ICU 0.02
- Stochastic Oscillator
- ABP 0.00
- ICU 33.33
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.